Search

everythinglearnresearchcommunity

for

Search:↓

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Certain drugs change freshwater snail shells to a "banana" shape.

A new mutation in the hairless gene causes hair loss and skin wrinkling in mice.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

Androgens can both increase body hair and cause scalp hair loss.

Pigs without the Hairless gene showed skin and thymus changes, useful for studying human hair disorders.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Finasteride causes abnormal growth in male mice cells at high doses.

Finasteride affects offspring's antioxidant enzymes in epididymis, possibly disrupting sperm maturation.

People with alopecia areata often have thyroid autoimmunity.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

Toxoplasma gondii infection may increase testosterone levels in males.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Androgens can both increase and decrease hair growth in different parts of the body.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Thyroid hormones help hair grow, reduce hair loss, and increase hair pigment.

Oxidative stress affects hair loss in men with androgenetic alopecia.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

The guide explains how to study human and mouse sebaceous glands using various staining and imaging techniques, and emphasizes the need for standardized assessment methods.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.